Developer docs
API playgroundTry for free, no card

Search company profiles

Valis Bioscience

Full company profile

uuid000b6bb

Namestring
Valis Bioscience
Legal namestring
Valis Bioscience, Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Valis Bioscience is a privately held clinical research technology company founded in 2016 and headquartered in Great Neck, NY, with additional offices in Berkeley, CA and New York, NY. The company develops a proprietary technology platform, branded ValisR, and a suite of digital measurement tools purpose-built for psychiatric and neurological disorder clinical trials, with stated specialization in psychedelic trials and rare/orphan CNS diseases. Its product portfolio includes the ACAM (Advanced Centralized Assessment Module) combining provisioned hardware and BYOD software for rater-administered video capture and independent scoring of clinical assessment visits, HIPAA-compliant remote video assessment solutions actively deployed in multiple Phase-III clinical trials, custom ePRO/eDiary applications, rater training and certification services delivered through the Trial.training portal, proprietary video capture and surveillance hardware/software, and bespoke mobile health application deployments. All digital tools are validated against HIPAA, GDPR, CCPA, 21 CFR Part 11, and the EU-U.S. Data Privacy Framework, with active listing on the DPF Program.

The company generates revenue through enterprise licensing of its technology platform on a recurring basis, supplemented by professional services revenue from rater training, eLearning, certification management, scientific consulting, and custom mHealth application deployment. Valis sells directly to pharmaceutical companies, biotech firms, and clinical trial sponsors through an enterprise field sales motion, targeting buyers developing compounds in CNS, psychedelic, and rare/orphan therapeutic areas. The company is led by CEO Ivan Goldensohn and co-founder/CSO Dr. Christian Yavorsky, who co-chairs the Rapid Acting Anti-Depressants Working Group at ISCTM, positioning the firm as scientist-led. Notable operational partners and collaborators include Aural Analytics (voice analytics), Medable (decentralized trial platform), NetraMark (AI/ML clinical data analysis), and NYU researcher Dr. Kelley O'Donnell on ketamine measurement standardization.

Short descriptiontext

Valis Bioscience is a private clinical research technology company that sells the ValisR platform and proprietary measurement tools, including remote video assessment, ACAM, ePRO/eDiary, and rater training, directly to pharmaceutical and biotech sponsors running psychiatric, neurological, psychedelic, and rare/orphan CNS clinical trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerkeley, United States
HQ citystring
Berkeley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial technology, CNS measurement tools, rater training services, electronic patient outcomes, decentralized clinical trials
Industry3 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Technology (eClinical / CNS measurement)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Technology Platform Licensing
TypeSubscription Recurring
Description

Licensing of proprietary technology platform including remote video assessment, ePRO/eDiary solutions, and video capture solutions to clinical trial sponsors. Platform is deployed in Phase-III clinical trials.

valisbioscience.com
2Professional Services - Rater Training
TypeProfessional Services
Description

Industry leading rater training, eLearning, certification management, and scientific consulting services provided to pharma companies and clinical trial organizations.

valisbioscience.com
3Mobile Health Application Deployment
TypeSubscription Recurring
Description

Proprietary and custom deployment of mobile health applications for clinical trials, including bespoke outcome measures.

valisbioscience.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1ACAM
Description

A streamlined hardware and software solution for secure, rater-friendly recording of assessment visits.

valisbioscience.com
+2 more records
Core offering1 text field

Valis Bioscience develops and licenses proprietary clinical research technology for psychiatric and neurological disorder trials, centered on the ValisR digital health platform. Its offerings include a HIPAA-compliant remote video assessment platform, the ACAM hardware+software video capture and scoring module, custom ePRO/eDiary applications, rater training and certification via the Trial.training portal, mobile health applications, and scientific/endpoint consulting services sold to pharmaceutical companies, biotech firms, and clinical trial sponsors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Remote video platform actively deployed in multiple Phase-III clinical trials
+1 more record
Product overview1 text field

Valis Bioscience offers a unified platform-plus-modules portfolio centered on the ValisR platform for measuring psychiatric and neurological disorders. The core platform is supplemented by specialized products including ACAM (hardware/software video capture and scoring), Remote Assessment Solutions (HIPAA-compliant remote video), and ePRO/eDiary (custom electronic patient-reported outcomes). Complementary services include Rater Training and Certification, Scientific Consulting, and proprietary mHealth Applications for digital therapeutics and adverse event prevention. The suite is designed for psychedelic trials, rare and orphan CNS disorders, and decentralized clinical trials, with all digital tools validated against HIPAA, GDPR, CCPA, 21 CFR Part 11, and EU-U.S. Data Privacy Framework.

Product and service8 records
1ValisR Platform
CategoryClinical trial technology platform
Description

Primary digital health platform that builds new digital tools to measure psychiatric and neurological disorders, integrating AI, decentralized clinical trial capabilities, and HIPAA/GDPR/21 CFR Part 11 compliant tools for mental health measurement in clinical trials. Sold to pharmaceutical companies, biotech firms, and clinical trial sponsors.

2ACAM (Advanced Centralized Assessment Module)
CategoryClinical trial video capture & scoring
Description

Streamlined hardware (provisioned device) and software (BYOD) solution for secure, rater-friendly recording of clinical assessment visits, with a portal for assigning, reviewing, and independently scoring recordings. Regulatory compliant and branded per sponsor use, deployable on aggressive trial timelines. Sold to clinical trial sponsors.

3Remote Assessment Solutions
CategoryRemote clinical assessment platform
Description

HIPAA-compliant remote video platform solution actively deployed in multiple Phase-III clinical trials for conducting psychiatric and neurological assessments remotely. Sold to clinical trial sponsors running decentralized trials.

4ePRO / eDiary Solutions
CategoryElectronic clinical outcome assessment (eCOA/ePRO)
Description

Custom eDiary and ePRO solutions deployed in weeks, designed by SME clinicians, with validation support on new measures. Includes training applications, mobile refresher courses, and eCertification for clinical trial sites. Sold to clinical trial sponsors.

5Rater Training and Certification
CategoryClinical trial training & certification services
Description

Industry-leading rater training, eLearning, and certification management services delivered via the Trial.training portal. Includes subject/caregiver education, learning management systems, and SME-led programs targeting data inconsistency in clinical trials. Sold to pharmaceutical companies and clinical trial sponsors.

6Video Capture and Surveillance Solution
CategoryClinical trial video surveillance hardware + software
Description

Proprietary video capture and surveillance solution combining hardware and software components for documenting and monitoring clinical trial assessments. Sold to clinical trial sponsors.

7mHealth Applications
CategoryMobile health (mHealth) applications
Description

Proprietary and custom deployment of mobile health applications for data collection, digital therapeutics, and patient monitoring in clinical trials. Sold to pharmaceutical companies and clinical trial sponsors.

8Scientific Consulting
CategoryClinical trial scientific consulting services
Description

Endpoint selection, management, and development plus scientific consulting services for clinical trial design and execution, provided by SME clinicians. Sold to pharmaceutical companies and clinical trial sponsors.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-10-01
Description

Cerevel hosted a reception at CNS Summit 2019. Cerevel is a biotech company developing neuroscience therapies.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Collaboration with NYU researcher Dr. Kelley O'Donnell on standardization of measurement outcomes in ketamine treatment at KRIYA Conference. Co-presentation on clinical measurement standardization.

3Betty-Jean Woodaman Foundation
Strategic tierMinorTypeOthers
Description

Woody's annual fundraising event for the Betty-Jean Woodaman foundation was held at CNS Summit 2019. Valis supports this scholarship foundation.

valisbioscience.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Valis CEO met with representatives from NIH, NIMH, and NIAAA at ACNP Annual Meeting 2019. These are key federal health research agencies involved in CNS research.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Aural Analytics provides AI-driven voice and speech biomarkers for neurological and psychiatric clinical trials. It is an existing Valis collaboration partner at the CNS Summit, making it a closely related emerging player in CNS digital measurement rather than a direct eCOA competitor.

TypeDirect peer
Description

Signant Health (formerly Bracket) provides eCOA/ePRO, rater training and certification, and decentralized clinical trial solutions, directly overlapping with ValisR, ACAM, ePRO/eDiary, and the Trial.training platform. Signant is the closest large-scale direct peer in CNS measurement and rater enablement.

TypeEmerging player
Description

Medable is a decentralized clinical trial platform partnering with sponsors on eConsent, eCOA, and remote monitoring. Valis has an established partnership dialog with Medable, indicating direct overlap in DCT enablement and remote data capture.

TypeBroad incumbent
Description

Veeva Vault CDB and Veeva ePRO compete with Valis's clinical data and eCOA offerings, particularly for sponsors standardizing on the Veeva platform across CTMS, EDC, and eCOA. It is a broad incumbent with deep enterprise relationships.

TypeBroad incumbent
Description

IQVIA provides eCOA, EDC, and full-service clinical trial operations including rater training and CNS expertise. Its scale and CNS delivery capability make it a broad incumbent competitor for the same enterprise pharma clients Valis targets.

TypeBroad incumbent
Description

WCG provides clinical trial technology, eCOA, and CNS-focused rater enablement services through its Clinical Endpoint Solutions business. It competes for the same sponsor training and central rating budgets that Valis pursues with Trial.training.

TypeDirect peer
Description

Clario (formed from ERT and Bioclinica) offers eCOA, electronic clinical outcome assessment, imaging, and respiratory solutions across CNS, oncology, and rare disease trials. Its eCOA and rater training portfolio directly competes with Valis's measurement and certification offerings.

TypeBroad incumbent
Description

Medidata (Dassault Systèmes) is a broad clinical trial platform with Rave EDC, eCOA, and DCT modules serving global pharma sponsors. It is a larger incumbent alternative for sponsors evaluating Valis's ePRO and centralized assessment capabilities.

TypeEmerging player
Description

Curebase is a decentralized clinical trial platform providing ePRO, remote monitoring, and home-based assessments. It competes with Valis in DCT delivery for CNS and rare disease sponsors seeking patient-centric, technology-driven trial designs.

10Oracle Health Sciences
TypeBroad incumbent
Description

Oracle Health Sciences (formerly Phase Forward) provides EDC, ePRO, and clinical trial analytics to large pharma. As a broad incumbent, it represents the 'build vs. buy' alternative for sponsors considering a specialist like Valis.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Valis Bioscience

Clinical Trial Technology (eClinical / CNS measurement)valisbioscience.com

Valis Bioscience is a private clinical research technology company that sells the ValisR platform and proprietary measurement tools, including remote video assessment, ACAM, ePRO/eDiary, and rater training, directly to pharmaceutical and biotech sponsors running psychiatric, neurological, psychedelic, and rare/orphan CNS clinical trials.

What Valis Bioscience does

Valis Bioscience is a privately held clinical research technology company founded in 2016 and headquartered in Great Neck, NY, with additional offices in Berkeley, CA and New York, NY. The company develops a proprietary technology platform, branded ValisR, and a suite of digital measurement tools purpose-built for psychiatric and neurological disorder clinical trials, with stated specialization in psychedelic trials and rare/orphan CNS diseases. Its product portfolio includes the ACAM (Advanced Centralized Assessment Module) combining provisioned hardware and BYOD software for rater-administered video capture and independent scoring of clinical assessment visits, HIPAA-compliant remote video assessment solutions actively deployed in multiple Phase-III clinical trials, custom ePRO/eDiary applications, rater training and certification services delivered through the Trial.training portal, proprietary video capture and surveillance hardware/software, and bespoke mobile health application deployments. All digital tools are validated against HIPAA, GDPR, CCPA, 21 CFR Part 11, and the EU-U.S. Data Privacy Framework, with active listing on the DPF Program.

The company generates revenue through enterprise licensing of its technology platform on a recurring basis, supplemented by professional services revenue from rater training, eLearning, certification management, scientific consulting, and custom mHealth application deployment. Valis sells directly to pharmaceutical companies, biotech firms, and clinical trial sponsors through an enterprise field sales motion, targeting buyers developing compounds in CNS, psychedelic, and rare/orphan therapeutic areas. The company is led by CEO Ivan Goldensohn and co-founder/CSO Dr. Christian Yavorsky, who co-chairs the Rapid Acting Anti-Depressants Working Group at ISCTM, positioning the firm as scientist-led. Notable operational partners and collaborators include Aural Analytics (voice analytics), Medable (decentralized trial platform), NetraMark (AI/ML clinical data analysis), and NYU researcher Dr. Kelley O'Donnell on ketamine measurement standardization.

Valis Bioscience firmographics

Firmographics
Name
Valis Bioscience
Legal name
Valis Bioscience, Inc.
Website
https://valisbioscience.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Valis Bioscience is a private clinical research technology company that sells the ValisR platform and proprietary measurement tools, including remote video assessment, ACAM, ePRO/eDiary, and rater training, directly to pharmaceutical and biotech sponsors running psychiatric, neurological, psychedelic, and rare/orphan CNS clinical trials.
Ownership category
akta.pro rank

Valis Bioscience industry classification

Industry
Product category
Clinical Trial Technology (eClinical / CNS measurement)
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAH
Therapeutic Companion Apps (Drug-Device-Digital Combination)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Clinical trial technology
  • CNS measurement tools
  • Rater training services
  • Electronic patient outcomes
  • Decentralized clinical trials

Where Valis Bioscience is headquartered

Location

Headquarters

HQ city
Berkeley
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Valis Bioscience business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Technology Platform Licensing: Licensing of proprietary technology platform including remote video assessment, ePRO/eDiary solutions, and video capture solutions to clinical trial sponsors. Platform is deployed in Phase-III clinical trials.
  2. Professional Services - Rater Training: Industry leading rater training, eLearning, certification management, and scientific consulting services provided to pharma companies and clinical trial organizations.
  3. Mobile Health Application Deployment: Proprietary and custom deployment of mobile health applications for clinical trials, including bespoke outcome measures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Valis Bioscience product offering

Product offering

Core offering

Valis Bioscience develops and licenses proprietary clinical research technology for psychiatric and neurological disorder trials, centered on the ValisR digital health platform. Its offerings include a HIPAA-compliant remote video assessment platform, the ACAM hardware+software video capture and scoring module, custom ePRO/eDiary applications, rater training and certification via the Trial.training portal, mobile health applications, and scientific/endpoint consulting services sold to pharmaceutical companies, biotech firms, and clinical trial sponsors.

Product overview

Valis Bioscience offers a unified platform-plus-modules portfolio centered on the ValisR platform for measuring psychiatric and neurological disorders. The core platform is supplemented by specialized products including ACAM (hardware/software video capture and scoring), Remote Assessment Solutions (HIPAA-compliant remote video), and ePRO/eDiary (custom electronic patient-reported outcomes). Complementary services include Rater Training and Certification, Scientific Consulting, and proprietary mHealth Applications for digital therapeutics and adverse event prevention. The suite is designed for psychedelic trials, rare and orphan CNS disorders, and decentralized clinical trials, with all digital tools validated against HIPAA, GDPR, CCPA, 21 CFR Part 11, and EU-U.S. Data Privacy Framework.

Differentiator

Problem solved

Functional benefit

Brands

  • ACAM: A streamlined hardware and software solution for secure, rater-friendly recording of assessment visits.
  • ValisR
  • Trial.training

Products and services

  • ValisR Platform Primary digital health platform that builds new digital tools to measure psychiatric and neurological disorders, integrating AI, decentralized clinical trial capabilities, and HIPAA/GDPR/21 CFR Part 11 compliant tools for mental health measurement in clinical trials. Sold to pharmaceutical companies, biotech firms, and clinical trial sponsors.
  • ACAM (Advanced Centralized Assessment Module) Streamlined hardware (provisioned device) and software (BYOD) solution for secure, rater-friendly recording of clinical assessment visits, with a portal for assigning, reviewing, and independently scoring recordings. Regulatory compliant and branded per sponsor use, deployable on aggressive trial timelines. Sold to clinical trial sponsors.
  • Remote Assessment Solutions HIPAA-compliant remote video platform solution actively deployed in multiple Phase-III clinical trials for conducting psychiatric and neurological assessments remotely. Sold to clinical trial sponsors running decentralized trials.
  • ePRO / eDiary Solutions Custom eDiary and ePRO solutions deployed in weeks, designed by SME clinicians, with validation support on new measures. Includes training applications, mobile refresher courses, and eCertification for clinical trial sites. Sold to clinical trial sponsors.
  • Rater Training and Certification Industry-leading rater training, eLearning, and certification management services delivered via the Trial.training portal. Includes subject/caregiver education, learning management systems, and SME-led programs targeting data inconsistency in clinical trials. Sold to pharmaceutical companies and clinical trial sponsors.
  • Video Capture and Surveillance Solution Proprietary video capture and surveillance solution combining hardware and software components for documenting and monitoring clinical trial assessments. Sold to clinical trial sponsors.
  • mHealth Applications Proprietary and custom deployment of mobile health applications for data collection, digital therapeutics, and patient monitoring in clinical trials. Sold to pharmaceutical companies and clinical trial sponsors.
  • Scientific Consulting Endpoint selection, management, and development plus scientific consulting services for clinical trial design and execution, provided by SME clinicians. Sold to pharmaceutical companies and clinical trial sponsors.

Quantifiable outcome

  • Remote video platform actively deployed in multiple Phase-III clinical trials
  • +1 more outcomes

Companies that use Valis Bioscience

Customer profile

Segments3 records

Ideal customer profiles2 records

Valis Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Valis Bioscience partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor.

  • Cerevel TherapeuticsminorStrategic or Co-development Partner · 1 October 2019Cerevel hosted a reception at CNS Summit 2019. Cerevel is a biotech company developing neuroscience therapies.
  • NYU / Dr. Kelley O'DonnellminorStrategic or Co-development Partner · 1 January 2019Collaboration with NYU researcher Dr. Kelley O'Donnell on standardization of measurement outcomes in ketamine treatment at KRIYA Conference. Co-presentation on clinical measurement standardization.
  • Betty-Jean Woodaman FoundationminorOthersWoody's annual fundraising event for the Betty-Jean Woodaman foundation was held at CNS Summit 2019. Valis supports this scholarship foundation.
  • NIH / NIMH / NIAAAminorStrategic or Co-development PartnerValis CEO met with representatives from NIH, NIMH, and NIAAA at ACNP Annual Meeting 2019. These are key federal health research agencies involved in CNS research.

Scale indicators2 records

Recent moves1 record

Expansion highlights5 records

Valis Bioscience competitors and assessment

Company assessment

Emerging players

  • Aural Analytics: Aural Analytics provides AI-driven voice and speech biomarkers for neurological and psychiatric clinical trials. It is an existing Valis collaboration partner at the CNS Summit, making it a closely related emerging player in CNS digital measurement rather than a direct eCOA competitor.
  • Medable: Medable is a decentralized clinical trial platform partnering with sponsors on eConsent, eCOA, and remote monitoring. Valis has an established partnership dialog with Medable, indicating direct overlap in DCT enablement and remote data capture.
  • Curebase: Curebase is a decentralized clinical trial platform providing ePRO, remote monitoring, and home-based assessments. It competes with Valis in DCT delivery for CNS and rare disease sponsors seeking patient-centric, technology-driven trial designs.

Direct peers

  • Signant Health: Signant Health (formerly Bracket) provides eCOA/ePRO, rater training and certification, and decentralized clinical trial solutions, directly overlapping with ValisR, ACAM, ePRO/eDiary, and the Trial.training platform. Signant is the closest large-scale direct peer in CNS measurement and rater enablement.
  • Clario: Clario (formed from ERT and Bioclinica) offers eCOA, electronic clinical outcome assessment, imaging, and respiratory solutions across CNS, oncology, and rare disease trials. Its eCOA and rater training portfolio directly competes with Valis's measurement and certification offerings.

Broad incumbents

  • Veeva Systems: Veeva Vault CDB and Veeva ePRO compete with Valis's clinical data and eCOA offerings, particularly for sponsors standardizing on the Veeva platform across CTMS, EDC, and eCOA. It is a broad incumbent with deep enterprise relationships.
  • IQVIA eCOA: IQVIA provides eCOA, EDC, and full-service clinical trial operations including rater training and CNS expertise. Its scale and CNS delivery capability make it a broad incumbent competitor for the same enterprise pharma clients Valis targets.
  • WCG (WIRB-Copernicus Group): WCG provides clinical trial technology, eCOA, and CNS-focused rater enablement services through its Clinical Endpoint Solutions business. It competes for the same sponsor training and central rating budgets that Valis pursues with Trial.training.
  • Medidata Solutions: Medidata (Dassault Systèmes) is a broad clinical trial platform with Rave EDC, eCOA, and DCT modules serving global pharma sponsors. It is a larger incumbent alternative for sponsors evaluating Valis's ePRO and centralized assessment capabilities.
  • Oracle Health Sciences: Oracle Health Sciences (formerly Phase Forward) provides EDC, ePRO, and clinical trial analytics to large pharma. As a broad incumbent, it represents the 'build vs. buy' alternative for sponsors considering a specialist like Valis.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Valis Bioscience social profiles

Digital presence

Valis Bioscience compliance and trust

Trust signal

Compliance5 records

Valis Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Valis Bioscience leadership team

Management profile

Number of profiles

Profiles2 records

Valis Bioscience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Valis Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valis Bioscience

What does Valis Bioscience do?

Valis Bioscience develops and licenses proprietary clinical research technology for psychiatric and neurological disorder trials, centered on the ValisR digital health platform. Its offerings include a HIPAA-compliant remote video assessment platform, the ACAM hardware+software video capture and scoring module, custom ePRO/eDiary applications, rater training and certification via the Trial.training portal, mobile health applications, and scientific/endpoint consulting services sold to pharmaceutical companies, biotech firms, and clinical trial sponsors.

Is Valis Bioscience a public or private company?

Valis Bioscience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Valis Bioscience founded?

Valis Bioscience was founded in 2018. It employs 11 to 50 people.

Where is Valis Bioscience based?

Valis Bioscience is headquartered in Berkeley, United States, in the North America region.

How does Valis Bioscience make money?

Three revenue lines are on record. Technology Platform Licensing is the primary driver. The others are professional Services - Rater Training and mobile Health Application Deployment.

Who are Valis Bioscience's main competitors?

Emerging players on record are Aural Analytics, Medable and Curebase. Direct peers are Signant Health and Clario. Broad incumbents are Veeva Systems, IQVIA eCOA, WCG (WIRB-Copernicus Group), Medidata Solutions and Oracle Health Sciences.

Does Valis Bioscience have an API?

No public API is recorded for Valis Bioscience.

What industry is Valis Bioscience in?

Valis Bioscience's product category is Clinical Trial Technology (eClinical / CNS measurement). Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales